AgomAb Raises €21m Series A To Regenerate Damaged Tissues

 
• By Mike Ward
  
Human antibody
AgomAb develops agonistic antibodies for regeneration of damaged tissues • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip